193 results on '"Prieto Peña D"'
Search Results
2. POS0077 EFFECTIVENESS OF JANUS KINASE INHIBITORS IN RELAPSING GIANT CELL ARTERITIS IN REAL-WORLD CLINICAL PRACTICE AND REVIEW OF THE LITERATURE
3. AB1262 MORTALITY IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: STUDY FROM A SINGLE UNIVERSITY HOSPITAL
4. POS0516 ESPANDE PROJECT: IMPROVEMENT OF PRIMARY CARE-RHEUMATOLOGY COORDINATION IN SPONDYLOARTHRITIS IN A HEALTH AREA IN NORTHERN SPAIN
5. AB1278 THE ROLE OF NLRP1 POLYMORPHISMS IN THE PATHOGENESIS OF GIANT CELL ARTERITIS
6. POS1424 TOCILIZUMAB IN EXTRACRANIAL LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: COMPARATIVE MULTICENTER STUDY
7. POS0864 NEWLY DIAGNOSE ANCA-ASSOCIATED VASCULITIS, IS THERE REALLY AN INCREASE IN CASES RELATED TO COVID-19 PANDEMIC? STUDY IN A SINGLE UNIVERSITY HOSPITAL
8. POS0861 INCIDENCE OF ANCA-ASSOCIATED VASCULITIS IN A NORTHERN SPANISH HEALTH REGION BETWEEN 2000-2023. A POPULATION-BASED STUDY
9. POS0082 DEVELOPMENT OF A DIAGNOSTIC PREDICTION MODEL FOR GIANT CELL ARTERITIS: SEQUENTIAL APPLICATION OF SOUTHEND GCA PROBABILITY SCORE AND ULTRASONOGRAPHY
10. AB0269 SLCO1B1 POLYMORPHISM IS NOT ASSOCIATED WITH ANTI-HMGCOAR IMMUNE-MEDIATED NECROTIZING MYOPATHY
11. AB1494 CLINICAL ASSOCIATIONS OF ANTI-RO52 ANTIBODIES DETECTED IN 150 PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES FROM A SINGLE REFERRAL CENTRE
12. AB1402 CORRELATION BETWEEN 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS WITH OTHER CRITERIA
13. AB1264 RENAL OUTCOME RELATED TO SMALL VESSELL VASCULITIS: A COMPARISON BETWEEN IGA AND ANCA-ASSOCIATED VASCULITIS FROM A SINGLE REFERRAL CENTRE
14. A Review of the Dermatological Complications of Giant Cell Arteritis
15. POS0730 PROGNOSTIC FACTORS AND EFFICACY OF DMARD USE IN GCA: RESULTS FROM THE PROSPECTIVE, LONGITUDINAL,MULTI-CENTRE HAS-GCA STUDY
16. AB0870 ANTI-HMGCR AUTOANTIBODY LEVELS IN THE FOLLOW-UP OF STATIN-INDUCED IMMUNE-MEDIATED NECROTIZING MYOPATHY. MULTICENTRIC STUDY OF 24 PATIENTS
17. AB0709 EFFECTIVENESS OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS IN CLINICAL PRACTICE. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW
18. POS0731 SOUTHEND GCA PROBABILITY SCORE (GCAPS) AND ULTRASOUND HALO SCORE (HS) AS MARKERS FOR DIAGNOSIS AND MONITORING OF GCA: RESULTS FROM THE PROSPECTIVE, MULTICENTER HAS-GCA STUDY
19. AB0871 REMISSION IN ANTI-HMGCR POSITIVE IMMUNE-MEDIATED NECROTIZING MYOPATHY WITHOUT THE USE OF GLUCOCORTICOIDS: A MULTICENTRIC STUDY OF 24 PATIENTS
20. AB0803 ANCA-ASSOCIATED VASCULITIS (AAV) AND RENAL DISEASE IN A MULTIDISCIPLINARY OUTPATIENT CLINIC IN NORTHERN SPAIN
21. POS0737 AGE AND SEX BIAS OF ULTRASOUND SCORES FOR DIAGNOSIS OF GIANT CELL ARTERITIS: INSIGHTS FROM THE PROSPECTIVE, LONGITUDINAL HAS-GCA STUDY
22. Deciphering the role of angiogenic T cells in the lung vasculopathy of rheumatoid arthritis, systemic sclerosis and other autoimmune diseases
23. POS0818 SOUTHEND PRE-TEST PROBABILITY SCORE AND HALO SCORE AS MARKERS FOR DIAGNOSIS AND MONITORING OF GCA: EARLY RESULTS FROM THE PROSPECTIVE HAS-GCA STUDY
24. AB1314 JANUS KINASE INHIBITORS IN REFRACTORY AUTOINFLAMMATORY SYNDROMES. TWO CASE REPORTS AND LITERATURE REVIEW.
25. POS0804 TOCILIZUMAB IN LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: MULTICENTRIC OBSERVATIONAL COMPARATIVE STUDY
26. AB0145 IgA VASCULITIS AND IgA NEPHROPATHY SHARE A SIMILAR IL33-IL1RL1 ASSOCIATION PATTERN
27. POS0203 PREDICTIVE SEVERITY FACTORS OF COVID-19 IN PATIENTS WITH RHEUMATIC IMMUNE MEDIATED DISEASES
28. AB0907 TREATMENT WITH UPADACINITIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTER STUDY OF FIRST PATIENTS OF CLINICAL PRACTICE
29. AB1431 EPIDEMIOLOGICAL AND GENETIC FEATURES OF ANTI-3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE NECROTIZING MYOPATHY IN NORTHERN SPAIN: SINGLE-CENTER EXPERIENCE
30. AB1341 ASSESSMENT OF COMMON FEMORAL VEIN INTIMA-MEDIA THICKNESS BY ULTRASOUND IN BEHÇET’S DISEASE: COMPARATIVE STUDY OF PATIENTS WITH OR WITHOUT VASCULAR INVOLVEMENT IN A NATIONAL REFERRAL CENTER
31. POS0128 MICROVASCULAR INVOLVEMENT IN BEHÇET’S DISEASE. STUDY OF NAILFOLD CAPILLAROSCOPY AND ENDOTHELIAL PROGENITOR CELLS IN A NATIONAL REFERRAL CENTER
32. AB0679 INTRAVENOUS INMUNOGLOBULIN IN INFLAMMATORY MYOPATHIES: EXPERIENCE OF A SINGLE REFERRAL CENTER
33. POS0405 INCREASED LEVELS OF CELLULAR ADHESION MOLECULES ARE LINKED TO THE PRESENCE OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH AUTOIMMUNE DISEASES
34. POS0052 ANGIOGENIC T CELLS AS RELEVANT PLAYERS IN THE LUNG VASCULOPATHY OF RHEUMATOID ARTHRITIS, SYSTEMIC SCLEROSIS AND OTHER AUTOIMMUNE DISEASES
35. AB1147 COVID 19 INFECTION IN PATIENTS WITH RHEUMATIC IMMUNE-MEDIATED DISEASES IN A SINGLE UNIVERSITY HOSPITAL. MATCHED CASE-CONTROL STUDY.
36. AB0146 BAFF, APRIL y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IgA VASCULITIS AND IgA NEPHROPATHY?
37. Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice
38. POS1467-HPR SEVERE RESPIRATORY INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS WITH BIOLOGIC THERAPY. COMPARATIVE STUDY BETWEEN VACCINATED AND NON VACCINATED PATIENTS
39. POS0113 BAFF-APRIL-BAFFR PATHWAY ON THE PATHOGENESIS OF IMMUNOGLOBULIN-A VASCULITIS
40. OP0060 COMPARATIVE STUDY ON ANTI-TNF VS TOCILIZUMAB FOR TREATMENT OF REFRACTORY UVEITIC CYSTOID MACULAR EDEMA DUE TO BEHCET’S DISEASE. MULTICENTER STUDY OF 49 PATIENTS
41. AB0365 CLINICAL, LABORATORY AND IMAGING OUTCOMES IN TOCILIZUMAB-TREATED PATIENTS WITH LARGE VESSEL-GIANT CELL ARTERITIS ACCORDING TO EARLY ONSET THERAPY
42. AB0688 SEVERITY OF COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATEDINFLAMMATORY DISEASES. STUDY IN A SINGLE UNIVERSITY HOSPITAL
43. POS1346 CLINICAL ASSOCIATIONS OF ANTI-RO52 ANTIBODIES IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES
44. AB0366 TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS
45. AB0430 CONTRIBUTION OF SCLERODERMA/MYOSITIS-RELATED ANTIBODIES DETECTED BY IMMUNOBLOT TO THE DIAGNOSIS OF SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES IN 134 PATIENTS FROM A SINGLE REFERRAL CENTER
46. AB0096 IGA VASCULITIS AND IGA NEPHROPATHY SHARE A SIMILAR IL17A ASSOCIATION PATTERN
47. POS1231 COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATED INFLAMMATORY DISEASES. EPIDEMIOLOGICAL STUDY IN A SINGLE UNIVERSITY HOSPITAL
48. POS0337 SOUTHEND PRE-TEST PROBABILITY SCORE AND HALO SCORE AS MARKERS FOR DIAGNOSIS AND MONITORING OF GCA: EARLY RESULTS FROM THE PROSPECTIVE HAS-GCA STUDY
49. AB0094 INCREASE OF ENDOTHELIAL PROGENITOR CELLS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
50. AB0026 DECREASE OF ANGIOGENIC T CELLS IN CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.